Lifevantage Corp — Form 8-K
Filed August 27, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 68/100
What the filing says
LifeVantage reported fiscal year 2026 revenue of $182.6 million, a 20.1% decline from $228.5 million in FY2025. Net income fell to $5.1 million ($0.40 per diluted share) from $9.8 million ($0.75 per share). Active accounts fell 21.2% to 104,000 from 132,000. The company acquired LoveBiome in October 2025 but faced steep declines in MindBody GLP-1 System sales (with $2.5M inventory obsolescence charge), reduced order volumes, and lower average order sizes. New CEO Terrence Moorehead (recently appointed) declined to issue FY2027 guidance pending strategic review. Cash position weakened to $14.9M from $20.2M; company is debt-free with $58.5M remaining in a $60M share repurchase authorization.
Why this rating
Revenue decline of ~$46M (20%) is material at $220M market cap (21% of size). Active account loss of 28K (21% decline) signals core business erosion. CEO transition amid deterioration is notable governance event. Bright spots: debt-free balance sheet, strong 77.6% gross margins, positive cash flow. Not existential but trajectory-changing.
See more from August 27, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.